Jiangsu Kanion Pharmaceutical Co Ltd (600557) — Tangible Net Worth Ratio
Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a Tangible Net Worth Ratio of 92.0% as of September 2025. This metric is calculated by deducting intangible assets (CN¥394.57 Million) from net assets (CN¥4.91 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Jiangsu Kanion Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Jiangsu Kanion Pharmaceutical Co Ltd Tangible Net Worth Ratio (1999–2024)
This chart shows how Jiangsu Kanion Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 26 annual periods from 1999 to 2024. As of September 2025, the ratio stands at 92.0%, reflecting net assets of CN¥4.91 Billion with intangible assets of CN¥394.57 Million CNY. For live market cap and overall valuation, see market value of Jiangsu Kanion Pharmaceutical Co Ltd.
Annual Tangible Net Worth Ratio for Jiangsu Kanion Pharmaceutical Co Ltd (1999–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Jiangsu Kanion Pharmaceutical Co Ltd from 1999 to 2024, covering 26 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Jiangsu Kanion Pharmaceutical Co Ltd (600557) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 92.4% | CN¥4.71 Billion | CN¥359.45 Million | CN¥6.91 Billion | ▼ -0.8 pp |
| 2023 | 93.1% | CN¥5.38 Billion | CN¥369.08 Million | CN¥7.12 Billion | ▲ +1.2 pp |
| 2022 | 91.9% | CN¥4.93 Billion | CN¥397.71 Million | CN¥6.80 Billion | ▲ +1.6 pp |
| 2021 | 90.3% | CN¥4.47 Billion | CN¥433.85 Million | CN¥6.02 Billion | ▲ +1.4 pp |
| 2020 | 88.9% | CN¥4.33 Billion | CN¥481.53 Million | CN¥6.12 Billion | ▼ -0.3 pp |
| 2019 | 89.2% | CN¥4.09 Billion | CN¥443.23 Million | CN¥6.11 Billion | ▲ +0.7 pp |
| 2018 | 88.5% | CN¥3.89 Billion | CN¥447.81 Million | CN¥5.60 Billion | ▲ +0.1 pp |
| 2017 | 88.4% | CN¥3.59 Billion | CN¥418.38 Million | CN¥5.39 Billion | ▲ +0.3 pp |
| 2016 | 88.0% | CN¥3.21 Billion | CN¥383.94 Million | CN¥4.73 Billion | ▼ -1.0 pp |
| 2015 | 89.1% | CN¥2.87 Billion | CN¥313.93 Million | CN¥4.30 Billion | ▼ -1.8 pp |
| 2014 | 90.9% | CN¥2.56 Billion | CN¥232.42 Million | CN¥4.15 Billion | ▲ +2.5 pp |
| 2013 | 88.4% | CN¥1.93 Billion | CN¥223.83 Million | CN¥3.43 Billion | ▼ -1.6 pp |
| 2012 | 90.1% | CN¥1.65 Billion | CN¥163.75 Million | CN¥3.12 Billion | ▼ -1.7 pp |
| 2011 | 91.7% | CN¥1.47 Billion | CN¥121.95 Million | CN¥2.58 Billion | ▲ +1.0 pp |
| 2010 | 90.8% | CN¥1.24 Billion | CN¥114.95 Million | CN¥1.99 Billion | ▼ -2.4 pp |
| 2009 | 93.1% | CN¥1.08 Billion | CN¥73.88 Million | CN¥1.45 Billion | ▲ +1.7 pp |
| 2008 | 91.5% | CN¥954.72 Million | CN¥81.48 Million | CN¥1.31 Billion | ▲ +1.9 pp |
| 2007 | 89.6% | CN¥557.95 Million | CN¥58.03 Million | CN¥1.03 Billion | ▲ +3.5 pp |
| 2006 | 86.1% | CN¥492.91 Million | CN¥68.76 Million | CN¥936.11 Million | ▲ +6.3 pp |
| 2005 | 79.7% | CN¥457.89 Million | CN¥92.95 Million | CN¥990.51 Million | ▼ -8.7 pp |
| 2004 | 88.4% | CN¥414.10 Million | CN¥47.89 Million | CN¥784.98 Million | ▼ 0.0 pp |
| 2003 | 88.5% | CN¥374.88 Million | CN¥43.25 Million | CN¥778.43 Million | ▼ -11.5 pp |
| 2002 | 100.0% | CN¥333.38 Million | CN¥0.00 | CN¥426.07 Million | ▲ +0.0 pp |
| 2001 | 100.0% | CN¥73.91 Million | CN¥0.00 | CN¥177.52 Million | ▲ +0.0 pp |
| 2000 | 100.0% | CN¥57.01 Million | CN¥0.00 | CN¥175.93 Million | ▲ +0.0 pp |
| 1999 | 100.0% | CN¥41.54 Million | CN¥0.00 | CN¥155.38 Million | — |